Alnylam Pharmace. buy Barclays PLC
Start price
25.06.24
/
50%
€221.10
Target price
25.06.25
€271.88
Performance (%)
25.69%
End price
26.06.25
€277.90
Summary
This prediction ended on 26.06.25 with a price of €277.90. The BUY prediction by Barclays_PLC finished with a performance of 25.69%. Barclays_PLC has a follow-up prediction for Alnylam Pharmace. where he still thinks Alnylam Pharmace. is a Buy. Barclays_PLC has 50% into this predictionAlnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Alnylam Pharmace. | -0.651% | -0.651% | 23.205% |
| iShares Core DAX® | -1,10 % | -6,08 % | 3,20 % |
| iShares Nasdaq 100 | 0,33 % | 2,33 % | 20,24 % |
| iShares Nikkei 225® | -1,08 % | -7,99 % | 27,55 % |
| iShares S&P 500 | -0,06 % | 0,88 % | 14,89 % |
Comments by Barclays_PLC for this prediction
In the thread Alnylam Pharmace. diskutieren
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its price target raised by analysts at Barclays PLC from $236.00 to $291.00. They now have an "overweight" rating on the stock.
Ratings data for ALNY provided by MarketBeat
In the thread Trading Alnylam Pharmace.
Die von Barclays_PLC gewählte maximale Laufzeit wurde überschritten
Current prediction by Barclays_PLC for Alnylam Pharmace.
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€395.60
31.10.25
31.10.25
€455.43
31.10.26
31.10.26
-30.61%
13.03.26
13.03.26
Stopped prediction by Barclays_PLC for Alnylam Pharmace.
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€292.50
28.01.26
28.01.26
€439.47
28.01.27
28.01.27
-6.15%
13.03.26
13.03.26
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€247.70
01.11.24
01.11.24
€303.07
01.11.25
01.11.25
58.42%
02.11.25
02.11.25
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€244.00
02.08.24
02.08.24
€270.16
02.08.25
02.08.25
40.57%
03.08.25
03.08.25